vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and indie Semiconductor, Inc. (INDI). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $58.0M, roughly 1.1× indie Semiconductor, Inc.). indie Semiconductor, Inc. runs the higher net margin — -53.8% vs -70.9%, a 17.1% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs -0.0%). Cytek Biosciences, Inc. produced more free cash flow last quarter ($-1.8M vs $-16.1M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 5.3%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
indie Semiconductor is a fabless semiconductor manufacturer focused on designing high-performance mixed-signal and embedded system-on-chip solutions for the automotive industry. Its products support advanced driver assistance systems, in-vehicle infotainment, connected car, and electric vehicle applications, serving global auto OEMs and tier 1 suppliers across major global markets.
CTKB vs INDI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $58.0M |
| Net Profit | $-44.1M | $-31.2M |
| Gross Margin | 52.9% | 37.3% |
| Operating Margin | -9.0% | -58.5% |
| Net Margin | -70.9% | -53.8% |
| Revenue YoY | 8.1% | -0.0% |
| Net Profit YoY | -557.1% | 9.1% |
| EPS (diluted) | — | $-0.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $58.0M | ||
| Q3 25 | $52.3M | $53.7M | ||
| Q2 25 | $45.6M | $51.6M | ||
| Q1 25 | $41.5M | $54.1M | ||
| Q4 24 | $57.5M | $58.0M | ||
| Q3 24 | $51.5M | $54.0M | ||
| Q2 24 | $46.6M | $52.4M | ||
| Q1 24 | $44.9M | $52.4M |
| Q4 25 | $-44.1M | $-31.2M | ||
| Q3 25 | $-5.5M | $-38.3M | ||
| Q2 25 | $-5.6M | $-39.0M | ||
| Q1 25 | $-11.4M | $-34.5M | ||
| Q4 24 | $9.6M | $-34.4M | ||
| Q3 24 | $941.0K | $-49.7M | ||
| Q2 24 | $-10.4M | $-19.2M | ||
| Q1 24 | $-6.2M | $-31.2M |
| Q4 25 | 52.9% | 37.3% | ||
| Q3 25 | 52.7% | 40.1% | ||
| Q2 25 | 52.3% | 40.6% | ||
| Q1 25 | 48.6% | 41.7% | ||
| Q4 24 | 58.5% | 42.6% | ||
| Q3 24 | 56.3% | 39.3% | ||
| Q2 24 | 54.6% | 42.2% | ||
| Q1 24 | 51.3% | 42.5% |
| Q4 25 | -9.0% | -58.5% | ||
| Q3 25 | -17.6% | -71.4% | ||
| Q2 25 | -23.3% | -83.3% | ||
| Q1 25 | -36.1% | -72.0% | ||
| Q4 24 | 5.2% | -58.4% | ||
| Q3 24 | -8.2% | -92.5% | ||
| Q2 24 | -18.3% | -70.0% | ||
| Q1 24 | -23.9% | -94.8% |
| Q4 25 | -70.9% | -53.8% | ||
| Q3 25 | -10.5% | -71.3% | ||
| Q2 25 | -12.2% | -75.6% | ||
| Q1 25 | -27.5% | -63.9% | ||
| Q4 24 | 16.8% | -59.2% | ||
| Q3 24 | 1.8% | -92.1% | ||
| Q2 24 | -22.4% | -36.6% | ||
| Q1 24 | -13.8% | -59.6% |
| Q4 25 | — | $-0.16 | ||
| Q3 25 | — | $-0.19 | ||
| Q2 25 | — | $-0.20 | ||
| Q1 25 | — | $-0.18 | ||
| Q4 24 | — | $-0.18 | ||
| Q3 24 | — | $-0.28 | ||
| Q2 24 | — | $-0.11 | ||
| Q1 24 | — | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $145.5M |
| Total DebtLower is stronger | — | $353.4M |
| Stockholders' EquityBook value | $341.7M | $358.0M |
| Total Assets | $461.5M | $840.8M |
| Debt / EquityLower = less leverage | — | 0.99× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $145.5M | ||
| Q3 25 | $93.3M | $160.9M | ||
| Q2 25 | $75.5M | $192.6M | ||
| Q1 25 | $95.3M | $236.6M | ||
| Q4 24 | $98.7M | $274.2M | ||
| Q3 24 | $162.3M | $96.9M | ||
| Q2 24 | $177.9M | $112.3M | ||
| Q1 24 | $168.8M | $138.2M |
| Q4 25 | — | $353.4M | ||
| Q3 25 | — | $353.5M | ||
| Q2 25 | — | $352.5M | ||
| Q1 25 | — | $379.0M | ||
| Q4 24 | — | $381.3M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $341.7M | $358.0M | ||
| Q3 25 | $378.6M | $369.2M | ||
| Q2 25 | $377.6M | $390.4M | ||
| Q1 25 | $379.6M | $405.6M | ||
| Q4 24 | $395.7M | $417.9M | ||
| Q3 24 | $385.5M | $458.6M | ||
| Q2 24 | $389.1M | $470.7M | ||
| Q1 24 | $392.6M | $432.9M |
| Q4 25 | $461.5M | $840.8M | ||
| Q3 25 | $494.9M | $855.1M | ||
| Q2 25 | $493.3M | $867.6M | ||
| Q1 25 | $482.6M | $909.0M | ||
| Q4 24 | $499.5M | $941.4M | ||
| Q3 24 | $491.2M | $797.5M | ||
| Q2 24 | $483.7M | $797.3M | ||
| Q1 24 | $492.1M | $803.6M |
| Q4 25 | — | 0.99× | ||
| Q3 25 | — | 0.96× | ||
| Q2 25 | — | 0.90× | ||
| Q1 25 | — | 0.93× | ||
| Q4 24 | — | 0.91× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $-14.4M |
| Free Cash FlowOCF − Capex | $-1.8M | $-16.1M |
| FCF MarginFCF / Revenue | -2.9% | -27.8% |
| Capex IntensityCapex / Revenue | 1.6% | 3.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $-71.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $-14.4M | ||
| Q3 25 | $-3.9M | $-6.2M | ||
| Q2 25 | $108.0K | $-7.6M | ||
| Q1 25 | $-125.0K | $-29.0M | ||
| Q4 24 | $2.0M | $-6.7M | ||
| Q3 24 | $13.2M | $-22.8M | ||
| Q2 24 | $6.2M | $-19.7M | ||
| Q1 24 | $4.0M | $-9.3M |
| Q4 25 | $-1.8M | $-16.1M | ||
| Q3 25 | $-4.6M | $-10.3M | ||
| Q2 25 | $-1.5M | $-13.6M | ||
| Q1 25 | $-974.0K | $-31.4M | ||
| Q4 24 | $1.1M | $-8.6M | ||
| Q3 24 | $12.2M | $-29.3M | ||
| Q2 24 | $5.2M | $-23.4M | ||
| Q1 24 | $3.4M | $-11.7M |
| Q4 25 | -2.9% | -27.8% | ||
| Q3 25 | -8.7% | -19.2% | ||
| Q2 25 | -3.2% | -26.4% | ||
| Q1 25 | -2.3% | -58.0% | ||
| Q4 24 | 1.9% | -14.8% | ||
| Q3 24 | 23.7% | -54.3% | ||
| Q2 24 | 11.0% | -44.7% | ||
| Q1 24 | 7.6% | -22.3% |
| Q4 25 | 1.6% | 3.0% | ||
| Q3 25 | 1.3% | 7.8% | ||
| Q2 25 | 3.5% | 11.6% | ||
| Q1 25 | 2.0% | 4.4% | ||
| Q4 24 | 1.6% | 3.2% | ||
| Q3 24 | 2.0% | 12.1% | ||
| Q2 24 | 2.3% | 7.0% | ||
| Q1 24 | 1.3% | 4.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
INDI
| Products | $55.7M | 96% |
| Services | $2.3M | 4% |
